Patents Assigned to sanofi-aventis Pharma Deutschland GmbH
  • Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
    Patent number: 7241595
    Abstract: The present invention relates to glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates for treating cancers.
    Type: Grant
    Filed: April 24, 2002
    Date of Patent: July 10, 2007
    Assignee: sanofi-aventis Pharma Deutschland GmbH
    Inventors: Cenek Kolar, Jörg Czech, Klaus Bosslet, Gerhard Seemann, Hans-Harald Sedlacek
  • yeast strain with functional expression of a Glut transporter
    Patent number: 7052900
    Abstract: The invention relates to a strain of the yeast Saccharomyces cerevisiae which, owing to deletion of the genomic sequences, no longer synthesizes hexose transporters and, as a consequence, can no longer grow on substrates with hexoses as the only carbon source, and whose ability of growing on a substrate with a hexose as the only carbon source is restored when it expresses a GLUT4 gene.
    Type: Grant
    Filed: February 5, 2002
    Date of Patent: May 30, 2006
    Assignee: sanofi-aventis Pharma Deutschland GmbH
    Inventors: Gunter Muller, Klaus-Peter Koller, Eckhard Boles, Roman Wieczorke, Silke Dlugai